http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I709575-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee6577ef55a630cc43920d866a40dfd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2a0afc71f2ab548fd8193ff63e383cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fddecd37d21f049a601f038d024a8769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32a61044f535b4d5a7f55647a2993b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee063bc9a9879c97231b25a33cccbe5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40702e198c4b5b948fe5b3a22412bee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05d1c75f75d2f237b2282ac5dedb32b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b1705c45281549db36100b9b826b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f99c0a27b160506641f66f240eece0de
publicationDate 2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-I709575-B
titleOfInvention Polymyxin derivatives and their use in combination therapy together with different antibiotics
abstract Provided are compounds of formula (III), and the use of compounds of formula (III) in methods of treatment, such as methods of treating a microbial infection. The compounds of formula (III) is: n nwhere -R 15 is an amino-containing group: n nand -R 1 , -R 2 , -R 3 , -R 4 , -R 8 , -R A , Q, -R 16 , -R 17 are as described in further detail in the description.
priorityDate 2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013072695-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467785127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466109875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126682413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467310137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466302622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448750648

Total number of triples: 33.